Register

COURSE DESCRIPTION: 
Please join us for a conference on Bladder Cancer Today: Molecular Insights and Therapeutic Advances with Spencer H. Bachow M.D. Dr. Bachow will describe the diagnosis of non–muscle-invasive, muscle-invasive, and metastatic urothelial carcinoma of the bladder, describe the pathogenesis of non–muscle-invasive, muscle-invasive, and metastatic urothelial carcinoma of the bladder and discuss evidence-based treatment approaches for muscle-invasive and metastatic urothelial carcinoma of the bladder.

TARGET AUDIENCE:
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Describe the diagnosis of non–muscle-invasive, muscle-invasive, and metastatic urothelial carcinoma of the bladder.
• Describe the pathogenesis of non–muscle-invasive, muscle-invasive, and metastatic urothelial carcinoma of the bladder.
• Discuss evidence-based treatment approaches for muscle-invasive and metastatic urothelial carcinoma of the bladder.
   

FACULTY AND DISCLOSURES:

Spencer H. Bachow, M.D.
Medical Oncologist and Hematologist
Lynn Cancer Institute 
Baptist Health Boca Raton Regional Hospital 
Affiliate Assistant Professor of Medicine
Florida Atlantic University Schmidt College of Medicine
Center for Hematology Oncology
Boca Raton, Florida
 

Spencer H. Bachow, M.D., faculty for this educational activity, is on the speakers’ bureau for Natera Inc. He is also an advisor for Eli Lilly and a consultant for AstraZeneca. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. These financial relationships have been mitigated.

John F. Rubin, M.D., FACP, director for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-1296402, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Laboratory Personnel, Athletic Trainers and Respiratory Techs. Baptist Health South Florida CE Broker Provider #50-182.